Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

Jan 16, 2014

What Is the Real Drug Development Cost for Very Small Biotech Companies?

A small biotech company, virtual or not, has nowhere near $2 billion to bring a drug to market. A simple calculation shows that it can be done for less than $250 million.

What Is the Real Drug Development Cost for Very Small Biotech Companies?

There are a growing number of companies with only one drug candidate in development and none on the market because of the rise of virtual companies. [Natalia Merzlyakova - Fotolia.com]

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

Cancer vs. Zika: What Worries You Most?

While Zika continues to garner a lot of news coverage, a Mayo Clinic survey reveals that Americans believe the country’s most significant healthcare challenge is cancer. Compared to other diseases, does the possibility of developing cancer worry you the most?

More »